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Summary
Being overweight and obese has become an increasingly serious clinical and socioeconomic 
problem worldwide. The rapidly rising prevalence of obesity has prompted studies on modi-
fiable, causative factors and novel treatment options for this disorder. Recent evidence indi-
cates that excessive weight gain that leads to being overweight and obese may result from 
alterations in gut microflora. Studies in humans and animals demonstrated that the compo-
sition of gut microbiota may differ in lean and obese subjects, suggesting that these differen-
ces result in the increased efficiency of caloric extraction from food, enhanced lipogenesis, 
and impaired central and peripheral regulation of energy balance. Other studies revealed an 
excessive increase in body weight in a significant percentage of people infected with human 
adenoviruses SMAM-1 and Ad-36. Dysregulation of adipocyte function by viruses appears to be 
the most likely cause of excessive fat accumulation in these individuals. Studies on the patho-
mechanisms related to the pathogenesis of obesity indicated that a high-fat diet triggers the 
inflammatory response in the hypothalamus, an event that promotes weight gain and further 
defends elevated body weight through the initiation of central leptin and insulin resistance 
and impairment of regenerative capacity of hypothalamic neurons. Exposure to a high-calorie 
diet appears to predispose individuals to obesity not only because of excessive caloric intake 
but also because of the induction of microbiota- and central inflammatory response-depen-
dent changes that lead to a dysregulation of energy balance.
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IntroductIon
Being overweight and obese is a major health problem 
in both developed countries and the developing world. 
Both have been recognized by the World Health Orga-
nization as a global epidemic in the 21st century. Obe-
sity is generally believed to be the leading public health 
problem [75]. An estimated 20% of the European popu-
lation suffers from obesity [34]. In Poland, according to 
POL-MONICA (Multinational MONItoring of Trends and 
Determinants in CArdiovascular Diseases) BIS, the pre-
valence of overweight individuals was 44% for men and 
31% for women, and obesity was diagnosed in 28% and 
29% of the population, respectively, in 2001 [80]. Obesity 
has become the growing threat to health and the lives 
of people worldwide because of considerable morbidity 
and mortality rates [85]. The most prevalent diseases in 
civilization, such as type 2 diabetes, hypertension, cardio-
vascular disease [35], fatty liver disease, and some forms 
of cancer [40], are known to be the sequelae of obesity. 
Because of the harmful effects associated with obesity, 
understanding its etiology is highly important. Obesity 
is currently considered a pandemic, chronic disease with 
multiple contributing etiologies. The factors involved in 
the pathogenesis of obesity include various genetic and 
non-genetic (e.g., environmental) causes. Renewed inte-
rest has been focused on the role of gut microbiota and 
viral infections in the development of obesity. The im-
portance of hypothalamic inflammation in the etiology 
of obesity has also been recently highlighted. Therefore, 
the present study focused on the possible relationship 
between excessive body weight gain and intestinal flora, 
viral infections, and diet-induced inflammatory processes 
in the hypothalamus. Recognizing the etiological factors 
involved in the development of obesity will allow a bet-
ter understanding of the mechanisms responsible for the 
worldwide obesity epidemic and help develop effective 
treatment methods for this disorder.
crIterIa for obesIty dIagnosIs
Obesity is defined as increased body weight caused by 
excessive fat accumulation, leading to health impairment. 
Ideally, the obesity diagnosis should be based on a direct 
demonstration of an increase in body fat. Various indi-
ces, such as body weight, weight and height percentiles, 
skinfold thickness, percentage of ideal body weight, and 
body mass index (BMI), have been used to estimate body 
fat content [10]. The most recommended and appropriate 
method to assess body fat percentage and screen for obe-
sity in adults is measuring the BMI. The BMI is a simple 
index of the weight-for-height ratio, calculated as weight 
divided by the square of height. It is expressed in metric 
units (kg/m2). A BMI between 24.9 and 30.0 kg/m2 indi-
cates being overweight. A BMI >30 kg/m2 indicates mild 
obesity. A BMI >40 kg/m2 corresponds to extreme obesity 
[74]. The BMI, however, does not specify the location and 
quantity of adipose tissue; therefore, it may be misleading 
and cause the classification of people who have well-de-
veloped muscle mass as being overweight. Conversely, 
one risk is not identifying obesity in individuals whose 
fat percentage is considerable but whose BMI does not 
exceed 30 kg/m2 [39]. Therefore, other adiposity asses-
sment methods (e.g., measurement of waist circumferen-
ce [WC], waist-to-hip ratio [WHR; defined as the ratio of 
waist circumference to hip circumference] [87], and Lean 
Body Mass [LBM]) [24] are used. Body fat distribution may 
also be measured using anthropometric methods, such 
as densitometry or electrical bioimpedance [77]. Accu-
rate data can also be obtained using magnetic resonance 
imaging or computed tomography, but the costs of these 
procedures limit their use [77]. Nonetheless, these tech-
niques may provide valuable medical information by al-
lowing researchers and clinicians to distinguish between 
abdominal visceral fat and subcutaneous fat.
revIew of the factors Involved In the etIology of obesIty
Obesity, despite the large diversity of causes and com-
plex pathogenesis, in most cases undoubtedly results 
from long-term positive energy balance. It occurs as a 
consequence of an inappropriate, high-calorie diet and 
low physical activity. The modern world allows people to 
easily access highly processed, energy-rich products, such 
as fat and sugar, and technical developments have made 
life easier, thus contributing to low physical activity and 
reduced energy expenditure. Even a small mismatch be-
tween energy intake and expenditure, applied over time, 
can lead to profound fat accumulation and severe obesity 
[98]. Moreover, readily available and commonly consumed 
foods with a high glycemic index are believed to cause 
overeating [62]. A diet high in fruits and vegetables and 
low in meat and fat is associated with a lower BMI [100].
The pathogenesis of primary obesity, the most common 
nutritional disorder, is multifactorial and involves inte-
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ractions between metabolic, environmental, psycholo-
gical cultural, and genetic factors. The metabolic factors 
involved in the pathogenesis of obesity include inherited 
traits that determine energy expenditure (i.e., whole-
-body fat oxidation rate, basal metabolic rate, and activity 
of the sympathetic nervous system) [84]. Recent studies 
showed that psychological factors, such as sleep depriva-
tion, may result in an increase in the incidence of obesi-
ty because of a decrease in leptin levels and increase in 
ghrelin levels, providing a powerful dual signal that the 
body has an energy deficit and should increase food inta-
ke [41,99]. Similarly, chronic stress may enhance appetite 
through augmented cortisol release and attenuated sex 
hormone secretion [9]. Social factors include the level of 
education, socioeconomic status, age, and gender, which 
have all been shown to affect the vulnerability to obesity 
[48,63,86]. Several lines of epidemiologic evidence, howe-
ver, suggest that genetic factors account for up to 80% of 
a person’s predisposition to develop obesity [60]. Genetic 
factors contribute to three types of obesity: monogenic, 
syndromic, and common. Monogenic obesity involves 
cases with a genetic defect that leads to a deficiency of 
appetite-suppressing hormones (e.g., leptin) or a lack of 
functional receptors involved in the transmission of satie-
ty signals (e.g., the melanocortin receptor-4 [MC4R]) [36]. 
Monogenic obesity is a rare disorder, but understanding 
its pathogenesis allows a detailed comprehension of the 
mechanisms of appetite control and, in some cases, the 
use of effective treatments. Syndromic obesity is defined 
as the co-occurrence of obesity and other inherited de-
velopmental and mental abnormalities. The best-known 
clinical examples of syndromic obesity are Prader-Willi 
syndrome, Bardet-Biedl syndrome, Alström syndrome, 
and Cohen syndrome [83]. Common obesity is the result 
of gene-environment interactions. Some genetic variants 
are known to be associated with an increased obesity risk 
[90]. Interestingly, genetic factors that predispose an indi-
vidual to obesity appear only under certain environmen-
tal conditions [78], thus indicating that the environment 
may change gene expression, likely because of epigenetic 
modifications [96]. Recently, the factors related to the “in-
ternal” environment of the body, such as gut microbiota, 
have been intensively studied with regard to their effect 
on energy balance.
how can gut mIcroflora contrIbute to obesIty?
Normal intestinal flora in humans consists of several phy-
la, including Firmicutes and Bacteroidetes, accounting for 
approximately 90% of all microbiota, and Proteobacteria, 
Fusobacteria, Verrucomicrobia, and Actinobacteria [93]. Firmi-
cutes contain more than 250 genera, including Lactobacil-
lus, Mycoplasma, Bacillus, and Clostridium, and Bacteroidetes 
include approximately 20 genera [8].
Many recently published studies have reported that alte-
rations in gut microbiota may contribute to the develop-
ment of obesity. Germ-free mice were shown to be resi-
stant to diet-induced obesity [7,82], and the colonization 
of these animals with normal intestinal flora obtained 
from their wildtype counterparts resulted in a rapid in-
crease in body fat content [5], indicating that gut micro-
biota can be considered a relevant factor in the pathoge-
nesis of obesity. Another study, however, demonstrated 
that germ-free mice were not protected from excessive 
weight gain when maintained on a high-fat diet [38]. A 
specific diet was shown to affect the species composition 
of intestinal flora. Feeding with a high-fat diet resulted 
in body weight gain and altered abundance of two main 
bacterial phyla in the gut in rodents (i.e., a decrease in 
Bacteroidetes and increase in Firmicutes) [43,92,103]. Si-
milar changes were found in humans who consumed a 
high-fat or high-calorie diet [11,47]. Consequently, the 
obese genotype is associated with an increase in the Fir-
micutes/Bacteroidetes ratio in mice and humans [54,55]. 
When obese individuals lose weight, the proportion of 
Firmicutes becomes similar to lean individuals [7,54]. Some 
authors, however, did not confirm the “high Firmicutes/
low Bacteroidetes” hypothesis. They either were not able 
to demonstrate any significant differences between the 
composition of gut microbiota in lean and obese indivi-
duals [32] or reported an increased occurrence of Bacte-
roidetes in individuals with a high BMI [89].
Gut microbiota have been shown to affect a variety of me-
chanisms related to digestive tract function, such as the 
production of vitamins, harvesting energy from the diet, 
fat storage in the body, the regulation of gastrointestinal 
hormones, protection from pathogens, and modulation 
of the inflammatory process in the intestines [16]. When 
lean, germ-free mice were colonized with microbiota ob-
tained from obese mice, they harvested more energy from 
food and gained more weight [104], further supporting 
the hypothesis that gut microbiota in obese animals po-
tentially promotes fat deposition. Bacteria present in the 
human alimentary tract use indigestible polysaccharides, 
such as cellulose and resistant starch, as a source of ener-
gy. Fermentation of these compounds by bacteria leads to 
the production of short-chain fatty acids (SCFAs; e.g., ace-
tic acid, propionic acid, and butyric acid). These SCFAs, in 
turn, may be used by a host organism to produce glucose 
and lipids (for review, see [90]). Therefore, this biochemical 
pathway enables the host to utilize additional compounds 
as nutrients and may be at least partially responsible for 
weight gain in previously germ-free animals colonized with 
bacteria. This hypothesis was supported by the discovery 
that feeding mice a high-fat, high-sugar diet altered the 
composition of gut microbiota in a way that promoted 
better carbohydrate utilization [103]. Importantly, similar 
observations were made in obese humans [104]. Firmicu-
tes, whose number increases in obese individuals as sta-
ted above, express genes that encode enzymes that break 
down otherwise indigestible dietary polysaccharides, thus 
allowing their digestion and absorption and increasing the 
ability to harvest energy from food [105]. Another expla-
nation of the role of gut microflora in the stimulation of 
weight gain is a mechanism related to fasting-induced adi-
pose factor (Fiaf), also referred to as angiopoietin-like-4 
(Angptl4) protein, a member of the angiopoietin-like pro-
tein family. Angptl4 is a lipoprotein lipase (LPL) inhibitor 274
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and powerful regulator of lipid metabolism [61,94] that 
is secreted into the blood by different organs. Germ-free 
mice are characterized by relatively high expression of this 
protein, but the introduction of microbiota into their body 
results in the suppression of Angptl4 in the intestinal epi-
thelium [5]. The suppression of Angptl4 results in increased 
lipase activity in adipose tissue, leading to the enhanced 
production of lipids and thus contributing to increased fat 
deposition [5]. Preliminary studies indicated that Angptl4-
-related mechanisms may also operate in humans [53]. 
Fat metabolism also depends on the activity of adenosine 
monophosphate-activated protein kinase (AMPK), which 
stimulates fatty acid oxidation. The tissue activity of this 
enzyme is noticeably higher in germ-free mice, likely con-
tributing to mechanisms that protect these animals from 
diet-induced obesity [4]. Consistent with this, mice main-
tained on a high-fat diet and treated with antibiotics had 
higher AMPK activity than before treatment [22].
Recent reports demonstrated that gut bacteria may affect 
energy balance by initiating the inflammatory process 
related to increased lipopolysaccharide (LPS) expression. 
Lipopolysaccharide derived from gut microbiota acts as 
a trigger for systemic inflammation by binding the CD14 
toll-like receptor-4 (TLR-4) complex at the surface of in-
nate immune cells [95]. Thus, LPS stimulates the secretion 
of proinflammatory cytokines (tumor necrosis factor a 
and interleukins 1 and 6) and contributes to the deve-
lopment of insulin resistance. Moreover, LPS was shown 
to link inflammation to metabolic syndrome induced by 
a high-fat diet [15]. Mice fed a high-fat diet were shown 
to have plasma LPS concentrations that were markedly 
higher than normal, a condition known as “metabolic 
endotoxemia” [14]. Based on the results of their study, 
Cani et al. [14] hypothesized that gut microbiota-induced 
chronic metabolic endotoxemia might be responsible for 
obesity and decreased insulin sensitivity. Ingestion of a 
high-fat meal was found to result in endotoxemia, even 
in lean individuals [33]. The role of intestinal flora in in-
flammation-dependent positive energy balance that leads 
to obesity was further supported by the finding that the 
modulation of gut microbiota by antibiotic treatment or 
dietary intervention was associated with reduced glucose 
intolerance, decreased body weight gain, and inflamma-
tion inhibition in mice [18,22,64]. Germ-free mice main-
tained on a high-fat diet did not develop either the inte-
stinal inflammation or obesity that occurred in mice with 
normal bacterial flora fed a diet rich in fat [30]. Studies in 
humans have confirmed the validity of the role of LPS in 
obesity-related metabolic disorders. Specifically, higher 
LPS concentrations were found in patients with type 2 
diabetes compared with patients in the control group 
who did not present this disorder [25]. Similarly, the blo-
od concentration of another inflammation indicator, C-
-related protein, was recently found to correlate with the 
Bacteroidetes/Firmicutes ratio in obese individuals [108].
The subsequent mechanism by which gut microbiota 
may affect energy balance is related to changes in ga-
strointestinal hormones involved in appetite control. 
The digestive system produces various hormones, such 
as glucagon-like peptide-1 (GLP-1), peptide YY (PYY), 
and cholecystokinin (CCK), which are known to inhibit 
appetite through an effect on brain feeding centers [26]. 
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Microbiota may indirectly influence the function of en-
teroendocrine cells through the release of SCFAs that, 
in turn, bind to the free fatty acid receptors FFAR2 and 
FFAR3 (also referred to as G-protein receptor 43 [GPR43] 
and G-protein receptor 41 [GPR41], respectively) in the 
rat [50], mouse [88], and human [88] intestine. Consistent 
with this finding, SCFAs were shown to increase the acti-
vity of the proglucagon gene and PYY promoter in STC1 
cells (i.e., an enteroendocrine cell line) [113] and conse-
quently the secretion of GLP-1 and PYY in mice [57]. Ad-
ministration of prebiotics (i.e., non-digestive saccharides 
that enhance microbial fermentation in the gut) resulted 
in the increased secretion of GLP-1 in rats [49] and GLP-1 
and PYY in humans [17]. Germ-free mice had markedly 
decreased expression of GLP-1, PYY, and CCK in the in-
testine [31]. Therefore, bacteria that are present in the 
digestive tract may modify feeding behavior by augmen-
ting satiety signals from the gut. Importantly, together 
with GLP-1, GLP-2 release was enhanced in rats treated 
with prebiotics, and this hormonal response may contri-
bute to the inhibition of the inflammatory process in the 
intestines in obese mice [19]. Moreover, gut microbiota 
were shown to affect the activity of the endocannabinoid 
system in mice, indicating that this mechanism may also 
be involved in the pathogenesis of obesity [70]. A recent 
hypothesis is that some nutritional patterns in infancy 
may predispose an individual to obesity in adulthood 
through a mechanism that involves gut bacteria-derived 
compounds that affect cell metabolism at the epigenetic 
level [67]. Collective mechanisms by which gut micro-
biota may contribute to the pathogenesis of obesity are 
shown in Fig. 1.
Considering treatments for obesity, nothing can replace 
a proper diet and physical activity, but manipulation of 
the gut ecosystem may represent a novel approach for 
treating obesity and related disorders. The use of vario-
us agents that modify gut microflora, such as antibiotics, 
prebiotics, probiotics (i.e., dietary supplements that con-
tain bacteria with beneficial health effects), and synbio-
tics (i.e., a mixture of pre- and probiotics), may result in 
changes in gut microflora that are importantly devoid 
of side effects and improve health status [46]. However, 
the diverse mechanisms by which gut microbiota affect 
metabolism and some discrepancies in research results 
obtained to date indicate that more research is needed 
to establish safe and effective methods for the treatment 
of obesity by manipulating gut bacteria.
vIral factors and obesIty: what’s new?
To date, several viruses associated with the development 
of obesity have been identified. Their involvement in the 
pathogenesis of obesity has been reviewed in detail previ-
ously [45]. Briefly, canine distemper virus (CDV) [59], Rous 
type 7 virus (RAV-7) [21], Borna disease virus (BDV) [73], 
SMAM-1 (avian adenovirus) [29], and scrapie [20] have 
been linked to abnormal adiposity in animals. Notably, 
human viruses, such as adenovirus (Ad) 36, Ad-37, and 
Ad-5, are associated with obesity in animals [2].
Importantly, studies in humans revealed a relationship 
between infectious pathogens and overweight/obese con-
ditions. For example, herpes simplex viruses have been 
considered a possible promoter of obesity [37]. Most of 
the data on the relationships between viral infections 
and obesity in humans, however, have been generated 
by studies on adenoviruses. The most important adeno-
viruses that are implicated in the development of obesity 
in humans are adenoviruses SMAM-1 and Ad-36. SMAM-1 
was the first virus that was shown to cause obesity in hu-
mans [29]. Patients who had antibodies against SMAM-1 
were characterized by a significantly higher body weight 
and BMI but, paradoxically, lower serum triglycerides 
and cholesterol compared with antibody-negative indi-
viduals [29]. Further studies reported a significant as-
sociation between the occurrence of obesity and Ad-36 
infection [1,3,58,101,111], although other investigations 
did not confirm the involvement of Ad-36 in human obe-
sity [12,42].
The pathomechanisms by which viruses might cause obe-
sity have not been fully elucidated. Some animal viruses 
that are involved in the development of obesity induce 
fat accumulation caused by alterations in hypothalamic 
function (for review, see [68]). However, no obvious histo-
pathologic changes in the hypothalamus in Ad-36-infect-
ed chickens and mice was demonstrated [28]. Moreover, 
increased adiposity in virus-infected animals occurred 
even when no significant changes in food intake were 
found (for review, see [2]). Therefore, viruses might con-
tribute to the development of obesity through a direct 
effect on adipose tissue. Indeed, Ad-36 was shown to af-
fect adiposity by upregulating the genes that are crucial 
for adipocyte differentiation [71,76] and through altered 
expression of the genes responsible for carbohydrate, 
lipid, and protein metabolism [110]. Importantly, this vi-
rus reduced leptin secretion from adipocytes [107], thus 
attenuating the most important satiety signal generated 
by adipose tissue. Moreover, Ad-36 was shown to cause 
chronic inflammation and promote the development of 
obesity by increasing the level of monocyte chemoat-
tractant protein-1 [72]. Considering the aforementioned 
epidemiologic and pathophysiologic data, further inves-
tigations are warranted to establish the connections be-
tween viral infection and obesity.
can dIet change the braIn? dIet-Induced hypothalamIc 
InflammatIon
A general consensus is that obesity is associated with 
increased blood levels of inflammatory markers, such as 
tumor necrosis factor α and interleukins [13]. Circulating 
cytokines [44] and nutrient excess caused by exposure to 
fatty acids and glucose in amounts that exceed the de-
mand of the organism [51] activate intracellular inflam-
matory pathways in various tissues and organs (e.g., liver, 
muscles, adipocytes, and endothelial cells). A key medical 
consequence of so-called metabolic inflammation is in-
sulin and leptin resistance [44]. In addition to peripheral 
inflammation, recently published studies indicate that 276
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overeating may cause similar proinflammatory changes 
in the hypothalamus, a brain structure that plays a cen-
tral role in the regulation of food intake. Feeding with a 
high-fat diet was found to induce inflammation [27] and 
the apoptosis of neurons in the hypothalamus, events 
associated with the resistance of hypothalamic neurons 
to leptin and insulin [69].
Recent studies have focused on the inflammatory re-
sponse to dietary fat. TLR4 signaling is believed to be 
the primary mechanism that links the high consumption 
of dietary fats to the induction of hypothalamic dysfunc-
tion that leads to obesity. TLR4 was found to mediate the 
increased expression of inflammatory cytokines and de-
velopment of leptin resistance in the hypothalamus in 
rats fed a high-fat diet or injected intracerebroventricu-
larly with saturated fatty acids [52,66]. TLR4 gene deletion 
was shown to protect mice against high-fat diet-induced 
obesity [102]. In peripheral tissues, TLR4 activation stimu-
lates intracellular signaling pathways, including inhibitor 
of nuclear factor k-B kinase b (IKKb) and nuclear tran-
scription factor kb (NFkb). The former induces the degra-
dation of IKKa, an inhibitor of NFkb. As a result, activated 
NFkb increases the expression of various genes, including 
those responsible for the immune response. A similar re-
sponse to chronic exposure to a high-fat diet involves the 
NFkb/IKKb pathway, which was recently demonstrated in 
the rat hypothalamus [109]. The importance of the NFkb/
IKKb pathway in the high-fat diet-induced leptin/insulin 
resistance of hypothalamic neurons responsible for the 
control of energy balance was confirmed by other studies 
[79,112]. In addition to NFkb/IKKb-induced leptin/insulin 
insensitivity, the NFkb/IKKb pathway may cause the dys-
regulation of hypothalamic feeding centers by impairing 
autophagy [65]. Autophagy is the self-degradation of cy-
toplasmic components through lisosomal enzymes and 
was recently implicated in the control of the activity of 
hypothalamic neurons that regulate food intake [81,96]. 
Finally, the NFkb/IKKb pathway might impair neurogen-
esis and, thus, reduce the regenerative capacity of hypo-
thalamic neurons involved in food intake control [56]. 
As mentioned above, prolonged exposure to a high-fat 
diet was found to enhance the apoptosis of hypothalam-
ic neurons. Such a mechanism, together with impaired 
neurogenesis, may contribute to irreversible pathological 
alterations in the hypothalamus. Indeed, switching rats 
from a high-fat diet to a standard diet did not decrease 
the hypothalamic levels of proinflammatory interleukins, 
despite normalizing caloric intake and reducing body 
weight [109], suggesting that the inflammatory process 
was still active 2 months after the change in diet. There-
fore, hypothetically, reexposure to a fat-rich diet might 
cause a return to overfeeding because of maintenance of 
an unbeneficial proinflammatory state in the hypothala-
mus, even in subjects who successfully lost weight. Nota-
bly, the presence of a local inflammatory process in brain 
areas responsible for food intake regulation was recently 
demonstrated in obese humans [23], and a substantial re-
duction of body weight resulted only in partial reversal 
of obesity-induced changes in the brain, including the 
hypothalamus [106].
conclusIons
Based on the “microbial” and “inflammatory” hypothe-
ses, a high-fat diet may contribute to the pathogenesis of 
obesity through pathomechanisms of both peripheral and 
central origin. The former is likely induced by changes in 
natural intestinal microflora that, in turn, result in the 
dysregulation of fat metabolism and a blunted gastro-
intestinal response to food intake. Similarly, viral infec-
tions might disturb the differentiation, metabolism, and 
cytokine response of adipose tissue. Direct dysregulation 
of brain feeding center function by a local inflammatory 
process caused by exposure to a diet rich in saturated fat-
ty acids may occur together with the aforementioned sys-
temic disorders, thus resulting in obesity. Understanding 
the etiology of obesity is important for proper therapeu-
tic and preventive interventions for this rapidly spread-
ing disorder. New studies should focus on probiotic- and 
prebiotic-induced beneficial changes in gut microbiota, 
test possible antiviral vaccines or drugs that are able to 
inhibit the harmful effects of viruses on body metabolism, 
and investigate the mechanisms and possible treatment 
modalities that may limit high-fat diet-related neuronal 
dysfunction.
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